C. Tropé
Impact in
- Reproductive Medicine top 2%
- Ovarian cancer diagnosis and treatment
- Obstetrics and Gynecology top 2%
- Endometrial and Cervical Cancer Treatments
Papers in
-
- Ovarian cancer diagnosis and treatment 22
-
- Endometrial and Cervical Cancer Treatments 13
- Uterine Myomas and Treatments 2
- Co-authors
- Kolbein Sundfør (3 shared papers)Heidi Lyng (2 shared papers)J. Kærn (13 shared papers)E K Rofstad (1 shared paper)Christian Marth (2 shared papers)Einar K. Rofstad (1 shared paper)Vera M. Abeler (4 shared papers)Ignace Vergote (6 shared papers)
In The Last Decade
C. Tropé
43 papers receiving 973 citations
Peers
Comparison fields: 5 of 65
- Reproductive Medicine 350
- Obstetrics and Gynecology 299
- Cancer Research 184
- Oncology 153
- Pathology and Forensic Medicine 78
Countries citing papers authored by C. Tropé
This map shows the geographic impact of C. Tropé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Tropé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Tropé more than expected).
Fields of papers citing papers by C. Tropé
This network shows the impact of papers produced by C. Tropé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Tropé. The network helps show where C. Tropé may publish in the future.
Co-authors
The 25 scholars most cited alongside C. Tropé, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 164 | |
| 2 | 2000 | 88 | |
| 3 | 2000 | 79 | |
| 4 | 1996 | 78 | |
| 5 | 1992 | 51 | |
| 6 | 2000 | 46 | |
| 7 | 1997 | 44 | |
| 8 | 2001 | 41 | |
| 9 | 1997 | 34 | |
| 10 | 1997 | 33 | |
| 11 | 1999 | 30 | |
| 12 | 1996 | 27 | |
| 13 | 1997 | 22 | |
| 14 | Melphalan with and without doxorubicin in advanced ovarian cancer. | 1987 | 20 |
| 15 | 1990 | 19 | |
| 16 | Adriamycin-methotrexate combination chemotherapy of advanced carcinoma of the cervix: a third look. | 1980 | 19 |
| 17 | 2004 | 18 | |
| 18 | 1983 | 18 | |
| 19 | Some aspects of prophylactic oophorectomy and ovarian carcinoma. | 1981 | 18 |
| 20 | Phase II study of spirogermanium in advanced ovarian malignancy. | 1981 | 18 |
About C. Tropé
C. Tropé is a scholar working on Reproductive Medicine, Obstetrics and Gynecology, Oncology, Genetics and Surgery, having authored 44 papers that have together received 1.0k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (22 papers), Endometrial and Cervical Cancer Treatments (13 papers), Estrogen and related hormone effects (4 papers), BRCA gene mutations in cancer (4 papers), Sarcoma Diagnosis and Treatment (2 papers), Cancer Treatment and Pharmacology (2 papers), Intraperitoneal and Appendiceal Malignancies (2 papers) and Uterine Myomas and Treatments (2 papers). The work is most often cited by research in Reproductive Medicine (350 citations), Obstetrics and Gynecology (299 citations), Cancer Research (184 citations), Oncology (153 citations) and Pathology and Forensic Medicine (78 citations). C. Tropé has collaborated with scholars based in Norway, Sweden and Belgium. Frequent co-authors include Kolbein Sundfør, Heidi Lyng, J. Kærn, E K Rofstad, Christian Marth, Einar K. Rofstad, Vera M. Abeler, Ignace Vergote, Marit Scheistrøen and Mathias Onsrud. Their work appears in journals such as Gynecologic Oncology, International Journal of Gynecological Cancer, Acta Oncologica, European Journal of Cancer and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.